Publication

Byline

Location

US Patent Issued to The Cleveland Clinic Foundation on Oct. 20 for "Protease inhibitors and methods of use" (Ohio Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,134, issued on Oct. 20, was assigned to The Cleveland Clinic Foundation (Cleveland). "Protease inhibitors and methods of use" was invented ... और पढ़ें


US Patent Issued to HEALX on Oct. 20 for "Treatment of plexiform neurofibroma with nitroxoline" (British Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,135, issued on Oct. 20, was assigned to HEALX LTD (Cambridge, Great Britain). "Treatment of plexiform neurofibroma with nitroxoline" was in... और पढ़ें


US Patent Issued to KALLYOPE on Oct. 20 for "Compositions for treating or preventing pain" (Illinois, New York, Pennsylvania, New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,136, issued on Oct. 20, was assigned to KALLYOPE INC. (New York). "Compositions for treating or preventing pain" was invented by Justine Ku... और पढ़ें


US Patent Issued to JIANGSU HENGRUI PHARMACEUTICALS, SHANGHAI HENGRUI PHARMACEUTICAL on Oct. 20 for "Salt types of tricyclic tetrahydro isoquinoline derivative" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,137, issued on Oct. 20, was assigned to JIANGSU HENGRUI PHARMACEUTICALS Co. LTD. (Lianyungang, China) and SHANGHAI HENGRUI PHARMACEUTICAL Co... और पढ़ें


US Patent Issued to Iaterion on Oct. 20 for "Methods and compositions for treating viral infections with double and triple combinations of antiviral and immune modulating compounds" (California Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,138, issued on Oct. 20, was assigned to Iaterion Inc. (Oakland, Calif.). "Methods and compositions for treating viral infections with doubl... और पढ़ें


US Patent Issued to ANTECIP BIOVENTURES II on Oct. 20 for "Bupropion as a modulator of drug activity" (New York Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,139, issued on Oct. 20, was assigned to ANTECIP BIOVENTURES II LLC (New York). "Bupropion as a modulator of drug activity" was invented by ... और पढ़ें


US Patent Issued to The Trustees of Columbia University in the City of New York on Oct. 20 for "Cancer treatment method combining immunotherapy and radiotherapy" (New York Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,140, issued on Oct. 20, was assigned to The Trustees of Columbia University in the City of New York (New York). "Cancer treatment method co... और पढ़ें


US Patent Issued to Sumitomo Pharma on Oct. 20 for "Medicament for treating cancer comprising optically active azabicyclo ring derivative" (Japanese, American Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,141, issued on Oct. 20, was assigned to Sumitomo Pharma Co. Ltd. (Osaka, Japan). "Medicament for treating cancer comprising optically activ... और पढ़ें


US Patent Issued to VERADERMICS on Oct. 20 for "Compositions and methods of use for modified release minoxidil" (Connecticut Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,142, issued on Oct. 20, was assigned to VERADERMICS Inc. (West Hartford, Conn.). "Compositions and methods of use for modified release mino... और पढ़ें


US Patent Issued to Kadmon on Oct. 20 for "Method of administering belumosudil for treatment of chronic graft versus host disease" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,143, issued on Oct. 20, was assigned to Kadmon Corp. LLC (Morristown, N.J.). "Method of administering belumosudil for treatment of chronic ... और पढ़ें